TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Anti-Obesity Prescription Market, Global Outlook and Forecast 2023-2029

Anti-Obesity Prescription Market, Global Outlook and Forecast 2023-2029

  • Category:Life Sciences
  • Published on : 06 June 2023
  • Pages :75
  • Formats:
  • Report Code:SMR-7704559
OfferClick for best price

Best Price: $2600

AntiObesity Prescription Market Size, Share 2023


Obesity is a public health problem. Obesity is a genetic and chronic metabolic disease involving accumulation of excessive or abnormal fat in the body. It contributes to risk of chronic conditions such as cancer, hypertension, cardiovascular diseases, diabetics, obstructive sleep apnea, ventilatory failure, renal failure and asthma. According to a World Health Organization (WHO) report published in 2014, around 3.4 million adults in the world die each year due to obesity related issues. Increasing prevalence of obesity among children and adults is posing a threat and developing nations. Effective intervention strategies such as increased physical activity, behavioral and dietary changes are commonly used to control and prevent obesity. Obesity has a major impact on population longevity and health related expense.

This report aims to provide a comprehensive presentation of the global market for Anti-Obesity Prescription, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Obesity Prescription. This report contains market size and forecasts of Anti-Obesity Prescription in global, including the following market information:

Global Anti-Obesity Prescription Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global Anti-Obesity Prescription Market Sales, 2018-2023, 2024-2029, (K Units)

Global top five Anti-Obesity Prescription companies in 2022 (%)

The global Anti-Obesity Prescription market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

There is increased use of anti-obesity prescription due to increasing obesity endemic. Sedentary lifestyle and junk food habits, increasing healthcare expenditure and rise in aging population are some of the key factors driving the growth for global anti-obesity prescription market. In addition, increasing healthcare awareness is also fuelling the growth of the global anti-obesity prescription market. However, side effects of anti-obesity drugs, high drug development cost and strict regulatory framework are some of the major factors restraining the growth for the global anti-obesity prescription market.

We surveyed the Anti-Obesity Prescription manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-Obesity Prescription Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global Anti-Obesity Prescription Market Segment Percentages, by Type, 2022 (%)

Bupropion and Naltrexone

Orlistat

Lorcaserin

Phentermine and Topiramate

Liraglutide

Global Anti-Obesity Prescription Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global Anti-Obesity Prescription Market Segment Percentages, by Application, 2022 (%)

Hospital Pharmacies

Retail Pharmacies

E-Commerce

Global Anti-Obesity Prescription Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global Anti-Obesity Prescription Market Segment Percentages, By Region and Country, 2022 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-Obesity Prescription revenues in global market, 2018-2023 (Estimated), ($ millions)

Key companies Anti-Obesity Prescription revenues share in global market, 2022 (%)

Key companies Anti-Obesity Prescription sales in global market, 2018-2023 (Estimated), (K Units)

Key companies Anti-Obesity Prescription sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

Zydus Cadila

Akrimax Pharmaceuticals

Zealand Pharma

Arrowhead Research

Arena Pharmaceuticals

Compellis Pharmaceuticals

Yungjin Pharm

Alpex Pharma

Bridge BioResearch

Outline of Major Chapters:

Chapter 1: Introduces the definition of Anti-Obesity Prescription, market overview.

Chapter 2: Global Anti-Obesity Prescription market size in revenue and volume.

Chapter 3: Detailed analysis of Anti-Obesity Prescription manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Anti-Obesity Prescription in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global Anti-Obesity Prescription capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.

Report Attributes Report Details
Report Title Anti-Obesity Prescription Market, Global Outlook and Forecast 2023-2029
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2022
Forecast Year 2030
Number of Pages 75 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Anti-Obesity Prescription Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Obesity Prescription Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Obesity Prescription Overall Market Size
2.1 Global Anti-Obesity Prescription Market Size: 2022 VS 2029
2.2 Global Anti-Obesity Prescription Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti-Obesity Prescription Sales: 2018-2029
3 Company Landscape
3.1 Top Anti-Obesity Prescription Players in Global Market
3.2 Top Global Anti-Obesity Prescription Companies Ranked by Revenue
3.3 Global Anti-Obesity Prescription Revenue by Companies
3.4 Global Anti-Obesity Prescription Sales by Companies
3.5 Global Anti-Obesity Prescription Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-Obesity Prescription Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-Obesity Prescription Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Obesity Prescription Players in Global Market
3.8.1 List of Global Tier 1 Anti-Obesity Prescription Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Obesity Prescription Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Obesity Prescription Market Size Markets, 2022 & 2029
4.1.2 Bupropion and Naltrexone
4.1.3 Orlistat
4.1.4 Lorcaserin
4.1.5 Phentermine and Topiramate
4.1.6 Liraglutide
4.2 By Type - Global Anti-Obesity Prescription Revenue & Forecasts
4.2.1 By Type - Global Anti-Obesity Prescription Revenue, 2018-2023
4.2.2 By Type - Global Anti-Obesity Prescription Revenue, 2024-2029
4.2.3 By Type - Global Anti-Obesity Prescription Revenue Market Share, 2018-2029
4.3 By Type - Global Anti-Obesity Prescription Sales & Forecasts
4.3.1 By Type - Global Anti-Obesity Prescription Sales, 2018-2023
4.3.2 By Type - Global Anti-Obesity Prescription Sales, 2024-2029
4.3.3 By Type - Global Anti-Obesity Prescription Sales Market Share, 2018-2029
4.4 By Type - Global Anti-Obesity Prescription Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Obesity Prescription Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 E-Commerce
5.2 By Application - Global Anti-Obesity Prescription Revenue & Forecasts
5.2.1 By Application - Global Anti-Obesity Prescription Revenue, 2018-2023
5.2.2 By Application - Global Anti-Obesity Prescription Revenue, 2024-2029
5.2.3 By Application - Global Anti-Obesity Prescription Revenue Market Share, 2018-2029
5.3 By Application - Global Anti-Obesity Prescription Sales & Forecasts
5.3.1 By Application - Global Anti-Obesity Prescription Sales, 2018-2023
5.3.2 By Application - Global Anti-Obesity Prescription Sales, 2024-2029
5.3.3 By Application - Global Anti-Obesity Prescription Sales Market Share, 2018-2029
5.4 By Application - Global Anti-Obesity Prescription Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-Obesity Prescription Market Size, 2022 & 2029
6.2 By Region - Global Anti-Obesity Prescription Revenue & Forecasts
6.2.1 By Region - Global Anti-Obesity Prescription Revenue, 2018-2023
6.2.2 By Region - Global Anti-Obesity Prescription Revenue, 2024-2029
6.2.3 By Region - Global Anti-Obesity Prescription Revenue Market Share, 2018-2029
6.3 By Region - Global Anti-Obesity Prescription Sales & Forecasts
6.3.1 By Region - Global Anti-Obesity Prescription Sales, 2018-2023
6.3.2 By Region - Global Anti-Obesity Prescription Sales, 2024-2029
6.3.3 By Region - Global Anti-Obesity Prescription Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Anti-Obesity Prescription Revenue, 2018-2029
6.4.2 By Country - North America Anti-Obesity Prescription Sales, 2018-2029
6.4.3 US Anti-Obesity Prescription Market Size, 2018-2029
6.4.4 Canada Anti-Obesity Prescription Market Size, 2018-2029
6.4.5 Mexico Anti-Obesity Prescription Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Anti-Obesity Prescription Revenue, 2018-2029
6.5.2 By Country - Europe Anti-Obesity Prescription Sales, 2018-2029
6.5.3 Germany Anti-Obesity Prescription Market Size, 2018-2029
6.5.4 France Anti-Obesity Prescription Market Size, 2018-2029
6.5.5 U.K. Anti-Obesity Prescription Market Size, 2018-2029
6.5.6 Italy Anti-Obesity Prescription Market Size, 2018-2029
6.5.7 Russia Anti-Obesity Prescription Market Size, 2018-2029
6.5.8 Nordic Countries Anti-Obesity Prescription Market Size, 2018-2029
6.5.9 Benelux Anti-Obesity Prescription Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Anti-Obesity Prescription Revenue, 2018-2029
6.6.2 By Region - Asia Anti-Obesity Prescription Sales, 2018-2029
6.6.3 China Anti-Obesity Prescription Market Size, 2018-2029
6.6.4 Japan Anti-Obesity Prescription Market Size, 2018-2029
6.6.5 South Korea Anti-Obesity Prescription Market Size, 2018-2029
6.6.6 Southeast Asia Anti-Obesity Prescription Market Size, 2018-2029
6.6.7 India Anti-Obesity Prescription Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Anti-Obesity Prescription Revenue, 2018-2029
6.7.2 By Country - South America Anti-Obesity Prescription Sales, 2018-2029
6.7.3 Brazil Anti-Obesity Prescription Market Size, 2018-2029
6.7.4 Argentina Anti-Obesity Prescription Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Obesity Prescription Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Anti-Obesity Prescription Sales, 2018-2029
6.8.3 Turkey Anti-Obesity Prescription Market Size, 2018-2029
6.8.4 Israel Anti-Obesity Prescription Market Size, 2018-2029
6.8.5 Saudi Arabia Anti-Obesity Prescription Market Size, 2018-2029
6.8.6 UAE Anti-Obesity Prescription Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Zydus Cadila
7.1.1 Zydus Cadila Company Summary
7.1.2 Zydus Cadila Business Overview
7.1.3 Zydus Cadila Anti-Obesity Prescription Major Product Offerings
7.1.4 Zydus Cadila Anti-Obesity Prescription Sales and Revenue in Global (2018-2023)
7.1.5 Zydus Cadila Key News & Latest Developments
7.2 Akrimax Pharmaceuticals
7.2.1 Akrimax Pharmaceuticals Company Summary
7.2.2 Akrimax Pharmaceuticals Business Overview
7.2.3 Akrimax Pharmaceuticals Anti-Obesity Prescription Major Product Offerings
7.2.4 Akrimax Pharmaceuticals Anti-Obesity Prescription Sales and Revenue in Global (2018-2023)
7.2.5 Akrimax Pharmaceuticals Key News & Latest Developments
7.3 Zealand Pharma
7.3.1 Zealand Pharma Company Summary
7.3.2 Zealand Pharma Business Overview
7.3.3 Zealand Pharma Anti-Obesity Prescription Major Product Offerings
7.3.4 Zealand Pharma Anti-Obesity Prescription Sales and Revenue in Global (2018-2023)
7.3.5 Zealand Pharma Key News & Latest Developments
7.4 Arrowhead Research
7.4.1 Arrowhead Research Company Summary
7.4.2 Arrowhead Research Business Overview
7.4.3 Arrowhead Research Anti-Obesity Prescription Major Product Offerings
7.4.4 Arrowhead Research Anti-Obesity Prescription Sales and Revenue in Global (2018-2023)
7.4.5 Arrowhead Research Key News & Latest Developments
7.5 Arena Pharmaceuticals
7.5.1 Arena Pharmaceuticals Company Summary
7.5.2 Arena Pharmaceuticals Business Overview
7.5.3 Arena Pharmaceuticals Anti-Obesity Prescription Major Product Offerings
7.5.4 Arena Pharmaceuticals Anti-Obesity Prescription Sales and Revenue in Global (2018-2023)
7.5.5 Arena Pharmaceuticals Key News & Latest Developments
7.6 Compellis Pharmaceuticals
7.6.1 Compellis Pharmaceuticals Company Summary
7.6.2 Compellis Pharmaceuticals Business Overview
7.6.3 Compellis Pharmaceuticals Anti-Obesity Prescription Major Product Offerings
7.6.4 Compellis Pharmaceuticals Anti-Obesity Prescription Sales and Revenue in Global (2018-2023)
7.6.5 Compellis Pharmaceuticals Key News & Latest Developments
7.7 Yungjin Pharm
7.7.1 Yungjin Pharm Company Summary
7.7.2 Yungjin Pharm Business Overview
7.7.3 Yungjin Pharm Anti-Obesity Prescription Major Product Offerings
7.7.4 Yungjin Pharm Anti-Obesity Prescription Sales and Revenue in Global (2018-2023)
7.7.5 Yungjin Pharm Key News & Latest Developments
7.8 Alpex Pharma
7.8.1 Alpex Pharma Company Summary
7.8.2 Alpex Pharma Business Overview
7.8.3 Alpex Pharma Anti-Obesity Prescription Major Product Offerings
7.8.4 Alpex Pharma Anti-Obesity Prescription Sales and Revenue in Global (2018-2023)
7.8.5 Alpex Pharma Key News & Latest Developments
7.9 Bridge BioResearch
7.9.1 Bridge BioResearch Company Summary
7.9.2 Bridge BioResearch Business Overview
7.9.3 Bridge BioResearch Anti-Obesity Prescription Major Product Offerings
7.9.4 Bridge BioResearch Anti-Obesity Prescription Sales and Revenue in Global (2018-2023)
7.9.5 Bridge BioResearch Key News & Latest Developments
8 Global Anti-Obesity Prescription Production Capacity, Analysis
8.1 Global Anti-Obesity Prescription Production Capacity, 2018-2029
8.2 Anti-Obesity Prescription Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Obesity Prescription Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Obesity Prescription Supply Chain Analysis
10.1 Anti-Obesity Prescription Industry Value Chain
10.2 Anti-Obesity Prescription Upstream Market
10.3 Anti-Obesity Prescription Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Obesity Prescription Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Key Players of Anti-Obesity Prescription in Global Market
Table 2. Top Anti-Obesity Prescription Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-Obesity Prescription Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-Obesity Prescription Revenue Share by Companies, 2018-2023
Table 5. Global Anti-Obesity Prescription Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti-Obesity Prescription Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-Obesity Prescription Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Anti-Obesity Prescription Product Type
Table 9. List of Global Tier 1 Anti-Obesity Prescription Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Obesity Prescription Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-Obesity Prescription Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anti-Obesity Prescription Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-Obesity Prescription Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anti-Obesity Prescription Sales (K Units), 2018-2023
Table 15. By Type - Global Anti-Obesity Prescription Sales (K Units), 2024-2029
Table 16. By Application ? Global Anti-Obesity Prescription Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anti-Obesity Prescription Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-Obesity Prescription Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anti-Obesity Prescription Sales (K Units), 2018-2023
Table 20. By Application - Global Anti-Obesity Prescription Sales (K Units), 2024-2029
Table 21. By Region ? Global Anti-Obesity Prescription Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anti-Obesity Prescription Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-Obesity Prescription Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anti-Obesity Prescription Sales (K Units), 2018-2023
Table 25. By Region - Global Anti-Obesity Prescription Sales (K Units), 2024-2029
Table 26. By Country - North America Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-Obesity Prescription Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anti-Obesity Prescription Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti-Obesity Prescription Sales, (K Units), 2024-2029
Table 30. By Country - Europe Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-Obesity Prescription Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anti-Obesity Prescription Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti-Obesity Prescription Sales, (K Units), 2024-2029
Table 34. By Region - Asia Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-Obesity Prescription Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anti-Obesity Prescription Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti-Obesity Prescription Sales, (K Units), 2024-2029
Table 38. By Country - South America Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-Obesity Prescription Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anti-Obesity Prescription Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti-Obesity Prescription Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-Obesity Prescription Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anti-Obesity Prescription Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti-Obesity Prescription Sales, (K Units), 2024-2029
Table 46. Zydus Cadila Company Summary
Table 47. Zydus Cadila Anti-Obesity Prescription Product Offerings
Table 48. Zydus Cadila Anti-Obesity Prescription Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Zydus Cadila Key News & Latest Developments
Table 50. Akrimax Pharmaceuticals Company Summary
Table 51. Akrimax Pharmaceuticals Anti-Obesity Prescription Product Offerings
Table 52. Akrimax Pharmaceuticals Anti-Obesity Prescription Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Akrimax Pharmaceuticals Key News & Latest Developments
Table 54. Zealand Pharma Company Summary
Table 55. Zealand Pharma Anti-Obesity Prescription Product Offerings
Table 56. Zealand Pharma Anti-Obesity Prescription Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Zealand Pharma Key News & Latest Developments
Table 58. Arrowhead Research Company Summary
Table 59. Arrowhead Research Anti-Obesity Prescription Product Offerings
Table 60. Arrowhead Research Anti-Obesity Prescription Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Arrowhead Research Key News & Latest Developments
Table 62. Arena Pharmaceuticals Company Summary
Table 63. Arena Pharmaceuticals Anti-Obesity Prescription Product Offerings
Table 64. Arena Pharmaceuticals Anti-Obesity Prescription Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Arena Pharmaceuticals Key News & Latest Developments
Table 66. Compellis Pharmaceuticals Company Summary
Table 67. Compellis Pharmaceuticals Anti-Obesity Prescription Product Offerings
Table 68. Compellis Pharmaceuticals Anti-Obesity Prescription Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Compellis Pharmaceuticals Key News & Latest Developments
Table 70. Yungjin Pharm Company Summary
Table 71. Yungjin Pharm Anti-Obesity Prescription Product Offerings
Table 72. Yungjin Pharm Anti-Obesity Prescription Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Yungjin Pharm Key News & Latest Developments
Table 74. Alpex Pharma Company Summary
Table 75. Alpex Pharma Anti-Obesity Prescription Product Offerings
Table 76. Alpex Pharma Anti-Obesity Prescription Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Alpex Pharma Key News & Latest Developments
Table 78. Bridge BioResearch Company Summary
Table 79. Bridge BioResearch Anti-Obesity Prescription Product Offerings
Table 80. Bridge BioResearch Anti-Obesity Prescription Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Bridge BioResearch Key News & Latest Developments
Table 82. Anti-Obesity Prescription Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Anti-Obesity Prescription Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Anti-Obesity Prescription Production by Region, 2018-2023 (K Units)
Table 85. Global Anti-Obesity Prescription Production by Region, 2024-2029 (K Units)
Table 86. Anti-Obesity Prescription Market Opportunities & Trends in Global Market
Table 87. Anti-Obesity Prescription Market Drivers in Global Market
Table 88. Anti-Obesity Prescription Market Restraints in Global Market
Table 89. Anti-Obesity Prescription Raw Materials
Table 90. Anti-Obesity Prescription Raw Materials Suppliers in Global Market
Table 91. Typical Anti-Obesity Prescription Downstream
Table 92. Anti-Obesity Prescription Downstream Clients in Global Market
Table 93. Anti-Obesity Prescription Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Obesity Prescription Segment by Type in 2022
Figure 2. Anti-Obesity Prescription Segment by Application in 2022
Figure 3. Global Anti-Obesity Prescription Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Obesity Prescription Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Obesity Prescription Revenue, 2018-2029 (US$, Mn)
Figure 7. Anti-Obesity Prescription Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Obesity Prescription Revenue in 2022
Figure 9. By Type - Global Anti-Obesity Prescription Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anti-Obesity Prescription Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anti-Obesity Prescription Sales Market Share, 2018-2029
Figure 12. By Type - Global Anti-Obesity Prescription Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Anti-Obesity Prescription Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anti-Obesity Prescription Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anti-Obesity Prescription Sales Market Share, 2018-2029
Figure 16. By Application - Global Anti-Obesity Prescription Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Anti-Obesity Prescription Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anti-Obesity Prescription Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anti-Obesity Prescription Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anti-Obesity Prescription Sales Market Share, 2018-2029
Figure 21. By Country - North America Anti-Obesity Prescription Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anti-Obesity Prescription Sales Market Share, 2018-2029
Figure 23. US Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anti-Obesity Prescription Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anti-Obesity Prescription Sales Market Share, 2018-2029
Figure 28. Germany Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 29. France Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anti-Obesity Prescription Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anti-Obesity Prescription Sales Market Share, 2018-2029
Figure 37. China Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 41. India Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anti-Obesity Prescription Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anti-Obesity Prescription Sales Market Share, 2018-2029
Figure 44. Brazil Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anti-Obesity Prescription Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anti-Obesity Prescription Sales Market Share, 2018-2029
Figure 48. Turkey Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anti-Obesity Prescription Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anti-Obesity Prescription Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Anti-Obesity Prescription by Region, 2022 VS 2029
Figure 54. Anti-Obesity Prescription Industry Value Chain
Figure 55. Marketing Channels

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount